Strides gets USFDA nod for generic drug with 180-day exclusivity https://ift.tt/j09VyhR

New Delhi, Jun 11 (PTI) Drug firm Strides Pharma Science on Saturday said its subsidiary has received approval from the US health regulator to market Ibuprofen Oral Suspension, used for the treatment of pain and fever, in the American market.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/X8cyaxZ
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.